Principal Financial Group Inc. cut its stake in Dolby Laboratories, Inc. (NYSE:DLB – Free Report) by 1.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 136,685 shares of the electronics maker’s stock after selling 1,524 shares during the quarter. Principal Financial Group Inc. owned approximately 0.14% of Dolby Laboratories worth $10,675,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of the stock. Savant Capital LLC raised its holdings in Dolby Laboratories by 2.0% in the 4th quarter. Savant Capital LLC now owns 6,274 shares of the electronics maker’s stock valued at $490,000 after acquiring an additional 125 shares during the period. Harbor Capital Advisors Inc. grew its position in shares of Dolby Laboratories by 5.6% in the fourth quarter. Harbor Capital Advisors Inc. now owns 2,571 shares of the electronics maker’s stock valued at $201,000 after purchasing an additional 136 shares during the last quarter. Mather Group LLC. increased its stake in shares of Dolby Laboratories by 36.8% during the fourth quarter. Mather Group LLC. now owns 528 shares of the electronics maker’s stock worth $41,000 after purchasing an additional 142 shares during the period. First Horizon Advisors Inc. lifted its holdings in Dolby Laboratories by 22.7% during the 3rd quarter. First Horizon Advisors Inc. now owns 790 shares of the electronics maker’s stock worth $60,000 after purchasing an additional 146 shares during the last quarter. Finally, Naples Global Advisors LLC boosted its stake in Dolby Laboratories by 0.4% in the 4th quarter. Naples Global Advisors LLC now owns 35,730 shares of the electronics maker’s stock valued at $2,791,000 after purchasing an additional 160 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.
Dolby Laboratories Stock Performance
NYSE:DLB opened at $81.72 on Friday. The company has a market cap of $7.80 billion, a price-to-earnings ratio of 30.05 and a beta of 0.98. Dolby Laboratories, Inc. has a fifty-two week low of $66.35 and a fifty-two week high of $89.66. The stock has a fifty day moving average price of $80.99 and a 200-day moving average price of $76.71.
Dolby Laboratories Dividend Announcement
Insiders Place Their Bets
In related news, CAO Ryan Nicholson sold 7,000 shares of the stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $84.07, for a total transaction of $588,490.00. Following the sale, the chief accounting officer now owns 29,758 shares in the company, valued at approximately $2,501,755.06. This trade represents a 19.04 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CMO Todd Pendleton sold 18,121 shares of Dolby Laboratories stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $83.75, for a total transaction of $1,517,633.75. Following the completion of the transaction, the chief marketing officer now directly owns 37,290 shares in the company, valued at $3,123,037.50. This trade represents a 32.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 77,459 shares of company stock worth $6,464,675 over the last ninety days. Corporate insiders own 38.39% of the company’s stock.
Wall Street Analyst Weigh In
DLB has been the topic of several recent research reports. Barrington Research reiterated an “outperform” rating and set a $100.00 price objective on shares of Dolby Laboratories in a research report on Thursday, February 13th. StockNews.com cut shares of Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research note on Friday, January 31st. Finally, Rosenblatt Securities reissued a “buy” rating and issued a $100.00 price objective on shares of Dolby Laboratories in a report on Thursday, January 30th.
Check Out Our Latest Research Report on Dolby Laboratories
Dolby Laboratories Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- The How and Why of Investing in Gold Stocks
- 5 Best Gold ETFs for March to Curb Recession Fears
- Consumer Staples Stocks, Explained
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories, Inc. (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.